Quality control MIC ranges used for telavancin with application of a revised CLSI reference broth microdilution...

Area of Science:

• Microbiology
• Clinical Pharmacy
• Infectious Diseases

Background:

• The broth microdilution method is standard for determining antimicrobial susceptibility.
• Telavancin is a lipoglycopeptide antibiotic used to treat serious Gram-positive bacterial infections.
• A revised telavancin broth microdilution method has been developed, potentially impacting Minimum Inhibitory Concentration (MIC) results.

Purpose of the Study:

• To reestablish quality control (QC) ranges for telavancin using the revised broth microdilution method.
• To ensure accurate and reliable susceptibility testing for key bacterial pathogens.

Main Methods:

• The study involved performing broth microdilution susceptibility testing with telavancin.
• Standardized bacterial strains, including Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, and Streptococcus pneumoniae ATCC 49619, were used.
• MIC values were determined and analyzed to establish new QC ranges.

Main Results:

• The revised method produced lower MIC results compared to the previous method.
• Updated MIC ranges for quality control were determined: Staphylococcus aureus ATCC 29213 (0.03 to 0.12 μg/ml), Enterococcus faecalis ATCC 29212 (0.03 to 0.12 μg/ml), and Streptococcus pneumoniae ATCC 49619 (0.004 to 0.015 μg/ml).

Conclusions:

• The established QC ranges are crucial for validating the revised telavancin susceptibility testing method.
• These updated ranges will support consistent and accurate clinical laboratory testing of telavancin efficacy.